đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
Primary Objective: ⢠To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781
The purpose of this trial is to clinically confirm that the manufacturing p...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00404651
The purpose of this study is to document the immunological response to the ...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00362336
Treatments Being Tested
To demonstrate that the immune response to hepatitis B antigen of the DTaP-...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00315055
Treatments Being Tested
This study is designed to evaluate in a controlled manner the effect of Pre...
Status
Completed
Location
Multiple Locations
Start Date
2003-10
Trial ID
NCT00772928
This randomized, parallel controlled, clinical-trial aims to evaluate the t...
Status
Unknown
Location
Zhongshan Ophthalmic Center, Sun Yat-sen University
Start Date
2016-03
Trial ID
NCT01759121
This study is a Phase 3, randomized, modified double-blind study which aims...
Status
Active Not Recruiting
Location
Investigational Site Number : 0560004
Start Date
2025-05-22
Trial ID
NCT06975878
Treatments Being Tested
The purpose of the study is to provide immunogenicity and safety data of th...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00401531
Primary Objective: * To demonstrate that the immune response of the DTaP-I...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00831311
Treatments Being Tested